Target-Mediated Drug Disposition (TMDD) Revisited: High Versus Low-Affinity Approximations of the TMDD Model

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Biochemistry and Molecular Biology

Background:

• Target-mediated drug disposition (TMDD) describes how drug binding to its target influences its pharmacokinetic profile.
• High-affinity binding in TMDD can lead to nonlinear pharmacokinetics, affecting drug clearance, especially for large molecules like monoclonal antibodies.
• Small molecules may exhibit different TMDD behaviors, where target binding can reduce systemic clearance.

Purpose of the Study:

• To derive simple expressions for TMDD behavior under high-affinity binding conditions.
• To unify the description of TMDD for both large and small molecules using a single modeling framework.
• To investigate the relationship between TMDD and Michaelis-Menten kinetics and identify limitations of the latter.

Main Methods:

• Developed a high-affinity approximation of the standard TMDD model.
• Derived simplified mathematical expressions for drug clearance and target suppression.
• Compared the derived approximations with existing data for both large and small molecule drugs.
• Introduced a correction factor for the Michaelis-Menten constant under specific elimination rates.

Main Results:

• Demonstrated that high-affinity TMDD can be described by simple expressions, unifying behaviors of large and small molecules.
• Showed that Michaelis-Menten approximation emerges under low-affinity conditions with slow systemic clearance.
• Identified a previously overlooked factor in the Michaelis-Menten constant relevant when elimination rates differ.
• Derived expressions for the free target to baseline ratio as a measure of target suppression.

Conclusions:

• The derived TMDD approximations provide a unified framework for understanding drug disposition influenced by target binding.
• The study clarifies the relationship between TMDD and Michaelis-Menten kinetics, highlighting their respective domains of applicability.
• The findings offer improved analytical tools for predicting and interpreting pharmacokinetic data for a wide range of drugs.